Reverse Takeover in France.
How a private company in France can go public in the United States by reverse takeover into a clean Nasdaq, NYSE American or OTC shell — and the home-market considerations that shape the transaction.
France pairs a large domestic market with a research base that produces a steady flow of technology, software and life-sciences companies, many of which now weigh a US listing against staying on Euronext Paris. The French exchange serves blue chips and a vibrant growth segment well, yet founders in deep tech and biotech frequently find US public investors more willing to fund long-horizon stories. A reverse takeover — merging a private French company into a listed Nasdaq, NYSE American or OTC shell — offers a defined route to a dollar quote alongside, or ahead of, a Paris presence.
- French PCG statutory accounts, and any group IFRS, require restatement and re-audit to PCAOB standards — typically the timetable-defining task.
- BSPCE and free-share employee plans common in French startups must be mapped carefully into any US-acceptable holding structure.
- Reorganising into a topco can trigger French exit-tax and contribution-of-securities analysis on value moving abroad.
- The France–US tax treaty and PFIC exposure for US holders warrant early specialist review before the merger is structured.
- Any parallel Euronext Paris or Euronext Growth ambitions should be reconciled with the US path from the outset.
France at a glance
| Home market | Euronext Paris |
|---|---|
| Home regulator | Autorite des Marches Financiers (AMF) |
| Currency | Euro (EUR) |
| Notable sectors | Technology and software, life sciences, luxury-adjacent consumer, and clean energy. |
| US venues | Nasdaq, NYSE American, and the OTC Markets (OTCQX, OTCQB) |
| Our role | Advisory and arranger of the reverse takeover; not a broker-dealer, law firm or auditor. |
Why France companies list in the United States
French companies pursue US markets for the scale of American growth capital and for an investor base that prices software and life-sciences innovation on forward potential rather than near-term earnings. A US listing hands a euro-denominated group a dollar acquisition currency for transatlantic expansion and a specialist analyst following that Paris coverage may not match for a given niche. France’s strong biotech and computer-science talent produces exactly the categories — drug development, enterprise software, climate technology — where dedicated US funds concentrate. A reverse takeover lets such a company reach that capital on a controlled timetable, an appealing alternative when a domestic IPO would compete for a narrower window of French growth-equity demand.
The France market and a US listing
At home, companies list on Euronext Paris, with the regulated market and the Euronext Growth segment catering to smaller issuers, all under AMF supervision. Euronext offers a genuinely pan-European order book and solid execution, but for early-stage biotech or deep-tech names the depth of specialist capital and the valuations on offer can trail US venues. A US reverse takeover works differently in mechanics: instead of an AMF-approved prospectus, the path runs through SEC disclosure, a public float and, for Nasdaq, a minimum US$4.00 bid price. Many French issuers keep the option of a dual profile, using a US quote for growth capital while retaining Euronext visibility in their home market.
Sectors driving France US listings
France’s standout sectors for US public investors are technology and software, life sciences, clean energy and a luxury-adjacent consumer segment with global brand power. The country’s biotech cluster and its strength in mathematics and computer science feed a pipeline of drug-development and enterprise-software companies that fit US thematic mandates, while French climate-technology firms attract energy-transition capital. Premium consumer and beauty-adjacent brands can also translate a French heritage into a compelling US equity story. Because American investors reward recognisable comparables, a French issuer able to point to listed US peers in its niche can frame a valuation that a Paris listing might treat more conservatively.
Cross-border structuring from France
A French SA or SAS group listing in the US commonly adopts a holding company acceptable to US markets; a Luxembourg, Dutch or Irish topco is often used for treaty and share-exchange efficiency, though the French operating entity typically remains beneath it. France applies no exchange controls to an outbound listing, but the reorganisation engages French merger and contribution-of-securities regimes, exit-tax rules on transferring value abroad, the France–US tax treaty, and PFIC analysis for US holders. Employee-shareholding (BSPCE) and free-share plans common in French startups also need mapping into the new structure. These are decisions for French and US tax and securities counsel; Reverse Takeover arranges the transaction rather than advising on law or tax.
Audit and reporting readiness
French companies prepare statutory accounts under French GAAP (PCG) and often group IFRS, so US readiness means presenting IFRS as issued by the IASB or US GAAP, audited to PCAOB standards by a PCAOB-registered firm. France’s dual statutory-auditor tradition and the availability of PCAOB-registered practices help, but assembling two or three years of restated, audited history — and documenting internal controls to US expectations — is usually the critical-path item. Commissioning the PCAOB audit early, and confirming the auditor’s registration and capacity, generally sets the realistic pace of the whole process.
Choose a US venue
The same France company can target different US venues depending on its size and readiness. Each page below sets out the route and the listing standards.
- Nasdaq listingFrance → Nasdaq
- NYSE American listingFrance → NYSE American
- OTC Markets listingFrance → OTC Markets
Exploring a US listing from Tell us about your company.
Start an enquiry →Reverse Takeover in France — frequently asked questions
Q1Can a French company keep its SA or SAS entity when listing in the US?
Usually, yes. A US listing generally involves adopting or inserting a holding company acceptable to US markets, often in a treaty-efficient European jurisdiction, with the French SA or SAS remaining beneath it. The precise structure should be settled with French and US counsel.
Q2How are BSPCE and free-share plans treated in a US reverse takeover?
French employee-incentive plans such as BSPCE and free shares need to be mapped into the new holding structure, with attention to French and US tax treatment. This is a legal and tax question for specialist counsel; Reverse Takeover arranges the transaction and does not advise on it.
Q3Do French GAAP accounts need converting for a US listing?
SEC-registered issuers present IFRS as issued by the IASB or US GAAP, audited under PCAOB standards. French PCG statutory accounts, and any group IFRS, generally require restatement and re-audit by a PCAOB-registered firm, which is usually the critical-path item and needs early specialist input.
Q4Is Reverse Takeover a broker-dealer?
No. Reverse Takeover is an advisory and arranger — not a registered broker-dealer, investment adviser, law firm or audit firm. Regulated work is performed by the US securities counsel, PCAOB-registered auditors and transfer agents we coordinate.
Related markets
This page is general, educational information about listing routes and is not investment, legal, tax, or accounting advice, nor an offer or solicitation. Regulatory details change and vary by circumstance; obtain advice from qualified US securities counsel and your home-market advisers. See our disclosures.